1. Knowledge Translation (and Exchange) for Vaccine-Preventable Diseases (VPDs) CPHA Conference May 27 th, 2014 Lisa Paddle, Nurse Advisor

2. Presentation Outline  What is Knowledge Translation and Exchange (KTE) and why is it important?  KTE in context of Vaccine-Preventable Disease Surveillance  The ‘right’ audience  The ‘right’ time  The ‘right’ tools  Additional Learning Resources/KTE Mechanisms KTE on Vaccine-Preventable Diseases 2

3. 3 What is knowledge translation (KT) / exchange (KTE)?  “a dynamic and iterative process that includes synthesis, dissemination, exchange and ethically-sound application of knowledge to improve the health of Canadians, provide more effective health services and products and strengthen the health care system” (Source: Canadian Institutes of Health Research)  This process takes place within a complex system of interactions between researchers and knowledge users that vary in intensity, complexity and level of engagement depending on the nature of the research and the findings as well as the needs of the particular knowledge user

4. Knowledge Translation Models KTE on Vaccine-Preventable Diseases 4  Based on 31 planned action theories  Designed to be used by broad range of audiences  Key is importance of appropriate relationships  Fluid, non-linear

5. KTE on Vaccine-Preventable Diseases 5 Knowledge translation is about the application and use of the best available science to benefit health and well- being. Knowledge output Knowledge uptake/ impact The right information to the right people in the right way at the right time

6. VPD Surveillance: How to translate science to knowledge KTE on Vaccine-Preventable Diseases 6

7. 7 Who were our key surveillance stakeholders? Immunization and Respiratory Infectious Diseases Professional organizations: Canadian Paediatric Society (CPS) Immunize Canada Society for Obstetricians & Gynaecologists (SOGC) Canadian Public Health Association (CPHA) Etc. Government: PHAC (other Centres & Divisions) National Microbiology Laboratory (NML) Health Canada (First Nations, Vaccine Regulation) Provincial / Territorial (P/T) VPD / immunization programs F-P-T / Expert Committees: Canadian Immunization Committee (CIC) National Advisory Committee on Immunization (NACI) Committee to Advise on Tropical Medicine and Travel (CATMAT) International organizations: Centres for Disease Control & Prevention (CDC) Pan-American Health Organization (PAHO) World Health Organization (WHO) Immunization providers: Local public health units Primary health providers Hospitals Long-Term Care Homes Occupational health services Research community: Canadian Association of Immunization research and Evaluation (CAIRE) PHAC-CIHR Influenza Research Network (PCIRN) Vaccine evaluation centres IMPACT Individual researchers & students General public: Individuals / parents Media Public advocacy groups

8. What was our key mechanism? KTE on Vaccine-Preventable Diseases 8

9. 9 Objectives of Vaccine-Preventable Disease Surveillance  To provide timely, quality national surveillance data to detect trends in disease incidence  To provide information to support program planning and evaluation, outbreak response and future policy and program decision-making  To increase knowledge and understanding of the epidemiology of vaccine preventable diseases through innovative enhanced surveillance systems and research

10. Goal of Knowledge Translation in the Context of VPD Surveillance To align national VPD surveillance products with the information needs of key partners & stakeholders and effectively (and efficiently) inform immunization and vaccine-preventable disease program decisions. VPD’s include: Invasive meningococcal disease (IMD)Varicella Invasive pneumococcal disease (IPD)Polio PertussisDiphtheria Measles Tetanus MumpsHaemophilus influenza disease RubellaGBS/iGAS* KTE on Vaccine-Preventable Diseases 10

11. KTE Strategy for Vaccine-Preventable Disease Surveillance  Notifiable Diseases On-line for aggregate case counts at the national level  Routine cycle for publication of surveillance reports up to 2023 (Canada Communicable Disease Reports)  Q1 (Polio/AFP; measles; rubella; CRS)  Q2 years (IMD)  Q 5 years (Invasive Bacterial Diseases including Hi, IPD, iGBS, iGAS, International Circumpolar Surveillance, Pertussis)  Exploring options around weekly online measles reports  VPD surveillance on Agency Website  All products (e.g. Canadian Immunization Guide) will “point” here.  National Advisory Committee on Immunization (NACI) Statements  For product or strain-specific epidemiologic analysis  Peer Review journals for specific level of analysis  Disease Guidelines for epidemiologic summaries 11 KTE on Vaccine-Preventable Diseases

12. Government of Canada Web Renewal Action Plan (GCWRAP) Out with the Old, in with the New 12  www.Canada.ca by the end of 2016 www.Canada.ca  One website  User-centric  Modernized, leaner  Accessible (hand-held devices as well as assistive technologies)  Resources + “This single site (Canada.ca) approach will require that the Government of Canada fundamentally transform its web presence to better meet the needs of Canadians by being user-centric.”

13. Immunization and Vaccines Landing Page (before) Website Renewal: Out with the Old, in with the New 13

14. KTE on Vaccine-Preventable Diseases 14 Immunization and Vaccines Landing Page (After) http://www.phac-aspc.gc.ca/im/index-eng.php

15.  General Public (plain language) AND Health Professional audiences  De-duplication  Audience-specific  Organized and easy to navigate  Hyperlinks to relevant content  Images/sounds, as appropriate  Surveillance section : How is surveillance done on this VPD in Canada?  Health Professionals: information and resources specific to Health Professionals 15 KTE on Vaccine-Preventable Diseases New Vaccine-Preventable Diseases Landing Pages

16. Select KTE Learning Resources  PHAC Knowledge Translation Primer (http://publications.gc.ca/collections/collection_2013/aspc-phac/HP35-37- 2012-eng.pdf)http://publications.gc.ca/collections/collection_2013/aspc-phac/HP35-37- 2012-eng.pdf  National Collaborating Centre for Methods and Tools (http://www.nccmt.ca/)http://www.nccmt.ca/  CIHR: Population and Public Health Institute (http://www.cihr- irsc.gc.ca/e/27155.html)http://www.cihr- irsc.gc.ca/e/27155.html  KT Clearinghouse: www.ktclearinghouse.cawww.ktclearinghouse.ca  Institute for Knowledge Mobilization (www.knowledgemobilization,net)www.knowledgemobilization,net  Health Evidence (www.health-evidence.org)www.health-evidence.org 16 KTE on Vaccine-Preventable Diseases Some KTE mechanisms for Vaccine-Preventable diseases Public Health Agency of Canada Website: Immunization and Vaccines Canadian Immunization Guide Canada Communicable Disease Reports (CCDR) CNPHI (Canadian Network for Public Health Intelligence) (Public Health Alerts)

17. Acknowledgements  Heather Deehan, Chief Vaccine Preventable Diseases (PHAC)  Anita Li, Tiffany Smith, Amanda Shane, Lindsey Sherrard, Epidemiologists VPD section (PHAC)  Dr. Shalini Desai, Medical Specialist (PHAC)  Nadine Abboud, Project Management Support (PHAC)  Monique St-Laurent, A/Director Vaccine and Immunization Program Surveillance Division (PHAC)  Dr. John Spika, Director General, Centre for Immunization and Respiratory Infectious Diseases (CIRID) (PHAC)  Robert Lerch, Oliver Baclic, Althea House, CIG secretariat (PHAC)  Tara Harris, Public Health Ontario(formerly PHAC) KTE on Vaccine-Preventable Diseases 17